|Articles|December 11, 2020
- Pharmaceutical Executive-12-01-2020
- Volume 40
- Issue 12
Pharmaceutical Executive, December 2020 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 5 years ago
For Investors, ’Tis the Season to be Gratefulabout 5 years ago
A ‘Sign’ of the Times: Digital Contract Transformationabout 5 years ago
Opening Digital Doors: Remote Selling During COVID-19about 5 years ago
The C-Suite’s Frontline Workers in Digital Changeabout 5 years ago
Guiding Advice for Leaders Through COVID and Beyondabout 5 years ago
EU Under Pressure to Make Decisions on Data Sharingabout 5 years ago
COVID and AMR: Crisis Reframes Antibiotics Fightabout 5 years ago
Here’s to Looking AheadNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
4
Taking Advantage of ‘Hidden Gem’ Talent Hubs
5

